← back to search

Maureane Hoffman

Duke University · US
Area of research
Hematology · Genetics
Research interest
Research interests include Blood Coagulation and Thrombosis Mechanisms, Hemophilia Treatment and Research, Platelet Disorders and Treatments, and Coagulation, Bradykinin, Polyphosphates, and Angioedema.
h-index
63
citations
16,211
works
273
NIH funding
primary concept
Medicine
email

Recent publications

The kinetics and interplay of thrombin inhibition by 4 plasma proteinase inhibitors.
2025cited by 0position: contributordoi
Ultrasoft platelet-like particles stop bleeding in rodent and porcine models of trauma.
2024cited by 19position: contributordoi
Emicizumab promotes factor Xa generation on endothelial cells.
2024cited by 2position: contributordoi
Thrombin generation and implications for hemophilia therapies: A narrative review
Research and Practice in Thrombosis and Haemostasis 2023cited by 41position: middledoi
Thrombin generation and implications for hemophilia therapies: A narrative review.
2023cited by 31position: contributordoi
Inhalation of an RNA aptamer that selectively binds extracellular histones protects from acute lung injury.
2023cited by 10position: contributordoi
Clinical Relevance of Preclinical and Clinical Studies of Four-Factor Prothrombin Complex Concentrate for Treatment of Bleeding Related to Direct Oral Anticoagulants.
2023cited by 8position: contributordoi
Analytical validation and quality control/quality assurance practices for improved rigor and reproducibility of biochemical assays in orthopaedic research.
2023cited by 0position: contributordoi
A commentary on "A rapid, sensitive and specific assay to measure TF activity based on chromogenic determination of thrombin generation".
2022cited by 0position: contributordoi
Trauma-induced coagulopathy
Nature Reviews Disease Primers 2021cited by 760position: middledoi
Trauma-induced coagulopathy.
2021cited by 533position: contributordoi
Thrombosis and novel hemophilia therapies: the fine line between clotting and bleeding.
2021cited by 8position: contributordoi
Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitors.
2021cited by 8position: contributordoi
Platelet-like particles improve fibrin network properties in a hemophilic model of provisional matrix structural defects.
2020cited by 15position: contributordoi
Nanosilver composite pNIPAm microgels for the development of antimicrobial platelet-like particles.
2020cited by 13position: contributordoi
EPCR knockout: inflaming the discussion.
2020cited by 1position: contributordoi
The central role of thrombin in bleeding disorders
Blood Reviews 2019cited by 118position: lastdoi
A unique protein kinase C-dependent pathway for tissue factor downregulation in pericytes.
2019cited by 1position: contributordoi
Bleeding risk in warfarinized patients with a therapeutic international normalized ratio: the effect of low factor IX levels
Journal of Thrombosis and Haemostasis 2013cited by 25position: middledoi
Mechanisms and monitoring of bypassing agent therapy
Journal of Thrombosis and Haemostasis 2012cited by 108position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

· 8 papers (2019–2025)Dougald M. Monroe · University of North Carolina at Chapel Hill6 papers (2013–2025) · 3 papers (2019–2025)Yesim Dargaud · Université Claude Bernard Lyon 13 papers (2012–2023)Claude Négrier · Université Claude Bernard Lyon 12 papers (2013–2019)Beverley J. Hunt · Guy's and St Thomas' NHS Foundation Trust2 papers (2021–2021)Ernest E. Moore · Kelly Services (United States)2 papers (2021–2021)Nicola J. Mutch · University College London2 papers (2021–2021) · 1 papers (2013–2013)Vaishali Verma · Bennett University1 papers (2021–2021)Benjamin Andress · Duke University1 papers (2023–2023)Ashley C. Brown · Technical University of Denmark1 papers (2024–2024)Nina Moiseiwitsch · University of North Carolina at Chapel Hill1 papers (2024–2024)L. Andrew Lyon · Chapman University1 papers (2024–2024)Drew W. Koch · North Carolina State University1 papers (2024–2024)Emily Mihalko · University of North Carolina at Chapel Hill1 papers (2024–2024) · 1 papers (2021–2021)Lucy Z Kornblith · Versiti Blood Center of Wisconsin1 papers (2021–2021) · 1 papers (2024–2024)A Mark Richards · L-3 Communications (United States)1 papers (2021–2021)